PharmaCyte Biotech, Inc. (PMCB)

CIK 1157075 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for PharmaCyte Biotech, Inc..

Recent SEC filings

FiledFormAccession number
Jul 29, 202610-K0001683168-26-005836
Jul 17, 20264/A0001683168-26-005622
Jul 17, 20264/A0001683168-26-005619
Jul 17, 20264/A0001683168-26-005621
Jul 17, 20264/A0001683168-26-005620
Apr 2, 202640001683168-26-002630
Apr 2, 202640001683168-26-002632
Apr 2, 20268-K0001683168-26-002613
Apr 2, 202640001683168-26-002631
Apr 2, 202640001683168-26-002633
Mar 18, 202640001683168-26-001989
Mar 18, 2026SCHEDULE 13G0001683168-26-001988
Mar 17, 202610-Q0001683168-26-001917
Mar 9, 2026ARS0001683168-26-001600
Mar 9, 2026DEF 14A0001683168-26-001593
Feb 27, 2026PRE 14A0001683168-26-001363
Feb 13, 2026SCHEDULE 13G/A0001213900-26-016526
Jan 7, 202640001683168-26-000147
Jan 7, 202640001683168-26-000148
Dec 18, 202510-Q0001683168-25-009259
Dec 15, 2025NT 10-Q0001683168-25-009154
Dec 12, 202540001683168-25-009113
Dec 12, 202540001683168-25-009114
Dec 12, 202540001683168-25-009115
Dec 12, 202540001683168-25-009116